user

RESVERATROL FOR THE CORRECTION OF MITOCHONDRIAL DISORDERS

被引：0
|
作者：
Costa, Lopes A. [1 ]
Boneh, A. [2 ]
Tarnopolsky, M. [3 ]
Thorburn, D. [2 ]
Rotig, A. [4 ]
Bastin, J. [1 ]
Djouadi, F. [1 ]
机构：
[1] Univ Paris 05, INSERM, U747, Paris, France
[2] Murdoch Children Res Inst, Melbourne, Vic, Australia
[3] MacMaster Univ, Hamilton, ON, Canada
[4] Hop Necker Enfants Malad, INSERM, U781, Paris, France
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [1] MITOCHONDRIAL DISORDERS AND THEIR CORRECTION IN NEUROLOGICAL DISEASES
    Sidorova, Olga
    [J]. ASEAN JOURNAL OF PSYCHIATRY, 2022, 23 : 1 - 7
  • [2] A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders
    De Paepe, Boel
    Van Coster, Rudy
    [J]. NUTRIENTS, 2017, 9 (09):
  • [3] Author Correction: Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation
    Pedro Norat
    Sauson Soldozy
    Jennifer D. Sokolowski
    Catherine M. Gorick
    Jeyan S. Kumar
    Youngrok Chae
    Kaan Yağmurlu
    Francesco Prada
    Melanie Walker
    Michael R. Levitt
    Richard J. Price
    Petr Tvrdik
    M. Yashar S. Kalani
    [J]. npj Regenerative Medicine, 6
  • [4] Mitochondrial Protection by Resveratrol
    Ungvari, Zoltan
    Sonntag, William E.
    de Cabo, Rafael
    Baur, Joseph A.
    Csiszar, Anna
    [J]. EXERCISE AND SPORT SCIENCES REVIEWS, 2011, 39 (03): : 128 - 132
  • [5] The Effects of Ascorbate, N-Acetylcysteine, and Resveratrol on Fibroblasts from Patients with Mitochondrial Disorders
    Douiev, Liza
    Soiferman, Devorah
    Alban, Corinne
    Saada, Ann
    [J]. JOURNAL OF CLINICAL MEDICINE, 2017, 6 (01):
  • [6] Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model
    Zhang, Xi
    Feng, Yifan
    Wang, Yuping
    Wang, Jing
    Xiang, Danni
    Niu, Weiran
    Yuan, Fei
    [J]. LIFE SCIENCES, 2018, 207 : 234 - 245
  • [7] The use of noben for correction of mitochondrial disorders in Friedrich's disease
    Ershova, M. V.
    Illarioshkin, S. N.
    Sukhorukov, V. S.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2007, 107 (09) : 32 - 37
  • [8] Resveratrol and mitochondrial pathway of apoptosis
    Hotnog, D.
    Roman, V.
    Brasoveanu, L. I.
    Billard, C.
    Kolb, J. P.
    [J]. FEBS JOURNAL, 2006, 273 : 125 - 125
  • [9] PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders
    Djouadi, F.
    Bastin, J.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 (02) : 217 - 225
  • [10] Author Correction: Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation (vol 6, pg 13, 2021)
    Norat, Pedro
    Soldozy, Sauson
    Sokolowski, Jennifer D.
    Gorick, Catherine M.
    Kumar, Jeyan S.
    Chae, Youngrok
    Yagmurlu, Kaan
    Prada, Francesco
    Walker, Melanie
    Levitt, Michael R.
    Price, Richard J.
    Tvrdik, Petr
    Kalani, M. Yashar S.
    [J]. NPJ REGENERATIVE MEDICINE, 2021, 6 (01)
12345